The rational use of neuromuscular blocking agents: the role of pancuronium.
D000731:Androstanes / Q000627:therapeutic use*; D008725:Bis-Trimethylammonium Compounds / Q000494:pharmacology / Q000627:therapeutic use; D005730:Ganglionic Blockers / Q000494:pharmacology; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D009467:Neuromuscular Depolarizing Agents / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D009469:Neuromuscular Junction / Q000098:blood supply; D003473:Neuromuscular Nondepolarizing Agents / Q000627:therapeutic use*; D010197:Pancuronium / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D013329:Structure-Activity Relationship; D013997:Time Factors
D000731:Androstanes; D008725:Bis-Trimethylammonium Compounds; D005730:Ganglionic Blockers; D009467:Neuromuscular Depolarizing Agents; D003473:Neuromuscular Nondepolarizing Agents; D010197:Pancuronium